BALTIMORE, MD, January 17, 2025 – INFORMS, the world’s largest association for professionals and students in operations research (O.R.), AI, analytics and data science, has unveiled six finalists for the prestigious 2025 Franz Edelman Award for achievement in advanced analytics, operations research and management science. Recognized as the pinnacle of achievement in the application of analytics and operations research, the award, often referred to as “The Nobel Prize” of O.R. and advanced analytics, celebrates groundbreaking research and innovations that are transforming industries, improving lives and shaping a smarter, more sustainable future.
Cutting-edge chips, especially those designed to power emerging AI applications, tend to receive the most attention in the media and generate the most excitement. However, so-called “legacy” chips are just as important — if not more — to our daily lives.
January is National Blood Donor Month and, not coincidentally, a time when donations tend to ebb. Every two seconds, someone in the U.S. needs blood for serious injuries, childbirth, cancer treatments and more, according to the Department of Health and Human Services.
An audio journey of how data and analytics save lives, save money and solve problems.
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578
Explore our resources for multiple topics including:
Loosening restrictions and the warmer weather are beginning to draw students outside where experts say gathering is safer — but still not risk free.
Tens of millions of people across the U.S. have received a coronavirus vaccine. So far, the majority of doses have been either the Moderna or Pfizer vaccine, both of which use mRNA to generate an immune response. These gene-based vaccines have been in the works for decades, but this is the first time they have been used widely in people.
The various Covid-19 vaccines currently being distributed around the globe have the potential to end the worst pandemic in a century. They also will mean hundreds of billions dollars in sales for the pharmaceutical companies that make them.
Good evening. I’m Deborah Netburn, a science and features writer at the Los Angeles Times, filling in for Thuc Nhi Nguyen for a few days. You may remember me from my previous stints with the newsletter — it’s nice to be back! It’s Monday, March 15, and here’s what’s happening with the coronavirus in California and beyond.
Developing the vaccines was a gamble for the all the companies that tried, even with most drug makers accepting government grands.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine